Overview

Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to compare the effects of ciprofibrate versus omega-3 fatty acid supplementation on the vascular structure and function in hypertensive patients with hypertriglyceridemia.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital Universitario Pedro Ernesto
Collaborator:
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Treatments:
Ciprofibrate
Criteria
Inclusion Criteria:

- Previous diagnosis of hypertension

- Patients with serum triglycerides levels ≥ 150 mg/dl and <500 mg/dl

- Patients on stable antihypertensive medication for at least 4 weeks

- Patients with food consumption maintained for at least 4 weeks

Exclusion Criteria:

- Smoking

- Secondary hypertension

- Hormone replacement therapy

- Diabetes mellitus

- Chronic kidney disease

- Known coronary artery disease

- Previous stroke

- Dyslipidemia severe, with LDL cholesterol> 160 mg/dL or triglycerides ≥ 500 mg/dl

- Use of statins or beta blockers